14-3-3蛋白在口腔鳞癌中的表达与作用机制研究进展

Abstract

Abstract: The 14-3-3 protein family is ubiquitous in eukaryotic cells and is a highly conserved family of acidic proteins. It acts as an adaptor protein involved in various regulatory processes of cells such as cell cycle, metabolism, apoptosis, and incidence of diseases. In recent years, studies have found that 14-3-3 protein is associated with the occurrence and development of various tumors, and can be used as a new target for early diagnosis and treatment of diseases. This article briefly describes the expression and role of the 14-3-3 protein family in oral squamous cell carcinoma.

Key words: 14-3-3 protein, oral squamous cell carcinoma, lymph node metastasis, targeted therapy

CLC Number:

　R739.85

References 43

[1]	de Juan J, Garcia J, Lopez M, et al.Inclusion of extracapsular spread in the pTNM classification system: a proposal for patients with head and neck carcinoma[J].JAMA Otolaryngol Head Neck Surg, 2013, 139(5):483-488
[2]	Neal CL, Xu J, Li P, et al.Overexpression of 14-3-3zeta in cancer cells activates PI3K via binding the p85 regulatory subunit[J].Oncogene, 2012, 31(7):897-906
[3]	Lee JJ, Lee JS, Cui MN, et al.BIS targeting induces cellular senescence through the regulation of 14-3-3 zeta/STAT3/SKP2/p27 in glioblastoma cells[J]. Cell Death Dis, 2014, 5:e1537.
[4]	Yu J, Chen L, Chen Y, et al.Wnt5a induces ROR1 to associate with 14-3-3zeta for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells[J].Leukemia, 2017, 31(12):2608-2614
[5]	Cau Y, Valensin D, Mori M, et al.Structure,function,involvement in diseases and targeting of 14-3-3 proteins: An update[J].Curr Med Chem, 2018, 25(1):5-21
[6]	Obsil T, Obsilova V.Structural basis of 14-3-3 protein functions[J].Semin Cell Dev Biol, 2011, 22(7):663-672
[7]	Freeman AK, Morrison DK.Proteins: diverse functions in cell proliferation and cancer progression[J].Semin Cell Dev Biol, 2011, 22(7):681-687
[8]	Pozuelo RM, Geraghty KM, Wong BH, et al.affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism,proliferation and trafficking[J].Biochem J, 2004, 379(Pt 2):395-408
[9]	Abdrabou A, Brandwein D, Wang Z.Differential subcellular distribution and translocation of seven 14-3-3 isoforms in response to EGF and during the cell cycle[J]. Int J Mol Sci, 2020, 21(1).
[10]	谢蕴灵, 罗海丹, 杨惠玲.影响肿瘤发生发展和治疗的细胞及分子机制[J].分子诊断与治疗杂志, 2018, 10(2):132-137
[11]	韩雪娇, 李艳春, 孙立春.与恶性肿瘤关系的研究进展[J].实用肿瘤学杂志, 2017, 31(6):543-547
[12]	郭冬芳, 党筝, 刘喆, 等.类风湿关节炎患者血清--η蛋白、免疫球蛋白的变化及其意义[J].中国实验诊断学, 2019, 23(5):784-787
[13]	Zhao S, Li B, Li C, et al.The apoptosis regulator 14-3-3eta and its potential as a therapeutic target in pituitary oncocytoma[J]. Front Endocrinol (Lausanne), 2019, 10:797.
[14]	王安杏, 马望歌, 陈方圆, 等.14-3-3η通过抑制内质网应激反应对H9c2心肌细胞的保护作用[J]. 中国医药导报, 2015(11):22-26.
[15]	Shen J, Jiang F, Yang Y, et al.eta is a novel growth-promoting and angiogenic factor in hepatocellular carcinoma[J].J Hepatol, 2016, 65(5):953-962
[16]	Tang Y, Lv P, Sun Z, et al.beta promotes migration and invasion of human hepatocellular carcinoma cells by modulating expression of MMP2 and MMP9 through PI3KAktNF-kappaB pathway[J].PLoS One, 2016, 11(1):e146070-
[17]	Li N, Wang H, Fan J, et al.Overexpression of 14-3-3theta promotes tumor metastasis and indicates poor prognosis in breast carcinoma[J].Oncotarget, 2014, 5(1):249-257
[18]	Zhao Y, Fang X, Fang H, et al.ATPR-induced G0 /G1 phase arrest in gastric cancer cells by regulating the binding of 14-3-3epsilon and filamin A[J]. Cancer Med, 2018:7(7), 3373-3384.
[19]	Morrison D.modulators of signaling proteins?[J].Science, 1994, 266(5182):56-57
[20]	Chan SW, Lim CJ, Chen L, et al.The Hippo pathway in biological control and cancer development[J].J Cell Physiol, 2011, 226(4):928-939
[21]	Lee CG, Park GY, Han YK, et al.Roles of 14-3-3eta in mitotic progression and its potential use as a therapeutic target for cancers[J].Oncogene, 2013, 32(12):1560-1569
[22]	Kamalesh D, Ramireddy S, Raguraman P, et al.Expediting dynamics approach to understand the influence of 14-3-3zeta causing metastatic cancer through the interaction of YAP1 and beta-TRCP[J].Mol Biosyst, 2017, 13(10):1981-1992
[23]	Han DC, Rodriguez LG, Guan JL.Identification of a novel interaction between integrin beta1 and 14-3-3beta[J].Oncogene, 2001, 20(3):346-357
[24]	Santoro MM, Gaudino G, Marchisio PC.The MSP receptor regulates alpha6beta4 and alpha3beta1 integrins via 14-3-3 proteins in keratinocyte migration[J].Dev Cell, 2003, 5(2):257-271
[25]	Barrallo-Gimeno A, Nieto M A.The Snail genes as inducers of cell movement and survival: implications in development and cancer[J].Development, 2005, 132(14):3151-3161
[26]	Hou Z, Peng H, White D E, et al.binding sites in the snail protein are essential for snail-mediated transcriptional repression and epithelial-mesenchymal differentiation[J].Cancer Res, 2010, 70(11):4385-4393
[27]	刘颜, 杨彦, 何俊闯, 等.协同非典型蛋白激酶-ι经上皮-间充质转化促进胆管癌侵袭转移[J].中华实验外科杂志, 2018, 35(9):1670-1673
[28]	Lu J, Guo H, Treekitkarnmongkol W, et al.zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition[J].Cancer Cell, 2009, 16(3):195-207
[29]	Ralhan R, Desouza LV, Matta A, et al.Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling,multidimensional liquid chromatography,and tandem mass spectrometry[J].Mol Cell Proteomics, 2008, 7(6):1162-1173
[30]	Matta A, Masui O, Siu KW, et al.Identification of 14-3-3zeta associated protein networks in oral cancer[J].Proteomics, 2016, 16(7):1079-1089
[31]	Mikami T, Maruyama S, Abe T, et al.Keratin 17 is co-expressed with 14-3-3 sigma in oral carcinoma in situ and squamous cell carcinoma and modulates cell proliferation and size but not cell migration[J].Virchows Arch, 2015, 466(5):559-569
[32]	Jin LM, Han XH, Jie YQ, et al.zeta silencing retards tongue squamous cell carcinoma progression by inhibiting cell survival and migration[J].Cancer Gene Ther, 2016, 23(7):206-213
[33]	Ralhan R, Masui O, Desouza LV, et al.Identification of proteins secreted by head and neck cancer cell lines using LC-MSMS: Strategy for discovery of candidate serological biomarkers[J].Proteomics, 2011, 11(12):2363-2376
[34]	Han X, Han Y, Jiao H, et al.zeta regulates immune response through Stat3 signaling in oral squamous cell carcinoma[J].Mol Cells, 2015, 38(2):112-121
[35]	Chauhan SS, Kaur J, Kumar M, et al.Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer[J]. Oncogenesis, 2015, 4:e147.
[36]	Kumar M, Matta A, Masui O, et al.Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer[J]. J Transl Med, 2015, 13:285.
[37]	Subramanian RR, Zhang H, Wang H, et al.Interaction of apoptosis signal-regulating kinase 1 with isoforms of 14-3-3 proteins[J].Exp Cell Res, 2004, 294(2):581-591
[38]	Li X H, Kikuchi K, Zheng Y, et al.Downregulation and translocation of nuclear ING4 is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma[J].Oral Oncol, 2011, 47(3):217-223
[39]	Ballone A, Centorrino F, Ottmann C.A case study in PPI modulation[J].Molecules, 2018, 23(6):1386-
[40]	Peng C, Jia X, Xiong Y, et al.The 14-3-3sigmaGSK3betabeta-cateninZEB1 regulatory loop modulates chemo-sensitivity in human tongue cancer[J].Oncotarget, 2015, 6(24):20177-20189
[41]	Matta A, DeSouza LV, Ralhan R, et al.Small interfering RNA targeting 14-3-3zeta increases efficacy of chemotherapeutic agents in head and neck cancer cells[J].Mol Cancer Ther, 2010, 9(10):2676-2688
[42]	Macha MA, Matta A, Chauhan S, et al.14-3-3 zeta is a molecular target in guggulsterone induced apoptosis in head and neck cancer cells[J]. BMC Cancer, 2010, 10:655.
[43]	Srivastava G, Matta A, Fu G, et al.Anticancer activity of pyrithione zinc in oral cancer cells identified in small molecule screens and xenograft model: Implications for oral cancer therapy[J].Mol Oncol, 2015, 9(8):1720-1735

Research progress of expression and action mechanism of 14-3-3 protein in oral squamous cell carcinoma

Knowledge

Abstract

Cite this article

share this article

References 43

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. Mechanism research of YAP1-FOS promoting cell proliferation, migration and EMT in oral squamous cell carcinoma [J]. , 2019, 39(7): 581-586.
[2]	. Advances in the study of factors related to the occurrence and development of oral squamous cell carcinoma mediated by PI3K/AKT pathway [J]. , 2019, 39(6): 552-556.
[3]	. Inhibitory effect of danshensu on oral squamous cell carcinoma CAL-27 cells in vitro [J]. , 2019, 39(2): 113-116.
[4]	. A clinicopathological study of the prognosis and metastasis of MMP-14 in oral cancer patients [J]. , 2018, 38(8): 685-689.
[5]	. DNA quantitative analysis of oral squamous cell carcinoma and its clinical significance [J]. , 2018, 38(7): 616-619.
[6]	. Influence of nobelitin on the proliferation，migration and invasion of oral squamous cell carcinoma Cal-27 cells [J]. , 2018, 38(6): 481-484.
[7]	. Non-invasive Human Papilloma Virus Detection of Oral leukoplakia and Squamous Cell Carcinomas [J]. , 2018, 38(6): 528-532.
[8]	. Expression regulation of microRNA and oral squamous cell carcinoma [J]. , 2018, 38(5): 476-480.
[9]	. Relationship between E-cadherin and MMP-1 expressions and prognosis in oral squamous cell carcinoma [J]. , 2018, 38(1): 39-43.
[10]	. Effect of staurosporine on cell proliferation and apoptosis in oral squamous cell carcinoma cell line CAL27 [J]. , 2017, 37(7): 598-602.
[11]	chen xin. Current situation of oral squamous cell carcinoma [J]. , 2017, 37(5): 462-465.
[12]	. The expressions of Slug and E-cadherin in oral squamous cell carcinoma [J]. , 2017, 37(3): 214-218.
[13]	. The prognostic significance of peripheral blood eosinophilia in oral squamous cell carcinoma after surgery [J]. , 2016, 36(6): 546-549.
[14]	. MicroRNA27b inhibits cell proliferation of oral squamous cell carcinoma through targeting FZD7 [J]. , 2016, 36(3): 200-205.
[15]	. A primary study of differentially expressed proteins in the serums of healthy people and patients with oral squamous cell carcinoma [J]. , 2016, 36(2): 105-108.